CES represents a safe intervention for conditions for which existing treatments, especially pharmacologic and invasive interventions pose significant risk for adverse side effects. It is especially beneficial in defined populations. These include those who refuse medications and psychotherapy, dual diagnosed patients, geriatric patients, females of child bearing age and during pregnancy. Like in any intervention, patients should be appropriately provided informed consent. This includes the state of the science on its efficacy for the condition for which it is being recommended. To effectively preclude its availability denies patients the ability to consider this modality and force them to choose from others with significantly greater risk.
Excerpts from “A View from the Trenches” written by Jason Worchel, M.D.More CES Research – https://www.cesultra.com/research-resources/